As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....